* Meta-terms correspond to biological or medical specialty concerned
with one or more keywords (or keywords hierarchies), qualifiers, or resource types.
Other terms also benefit from this structure, when the topic warrants it, eg education.
See the list.
Preferred Label : genetics;
True Meta (CISMeF) : O;
Origin ID : MT58;
UMLS CUI : C0017398;
Automatic exact mappings (from CISMeF team)
CISMeF Resource Types
FMA entities
ICD-10 codes
Indication(s)
MeSH
MeSH qualifiers
SNOMED CT concepts
SNOMED int. notions
See also
See also (suggested by CISMeF)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
https://cps.ca/fr/documents/position/ssn-ssno
2025
Canada
practice guideline
opiate agonist, nos
weaning
charge association
infant, newborn
patient care management
analgesics, opioid
CHARGE syndrome
substance withdrawal syndrome
practice guidelines as topic
newborn, nos
risk-taking
neonatal abstinence syndrome
opioids
---
https://ansm.sante.fr/tableau-acces-derogatoire/kaftrio-75-mg-50-mg-100-mg-comprime-pellicule-kalydeco-150-mg-comprime-pellicule
2025
false
false
false
France
French
cystic fibrosis
guidelines for drug use
continuity of patient care
drug therapy, combination
administration, oral
ivacaftor, tezacaftor and elexacaftor
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
tezacaftor
elexacaftor
adult
adolescent
ivacaftor
trikafta
drug combinations
drug information
---
https://www.has-sante.fr/jcms/p_3573729/fr/interet-des-techniques-d-amplification-des-acides-nucleiques-taan-multiplex-dans-la-prise-en-charge-medicale-des-infections-respiratoires-basses
2025
false
false
false
France
Lower respiratory tract infection (disorder)
health technology assessment
respiratory tract infections
nucleic acid amplification techniques
---
https://www.has-sante.fr/jcms/p_3577036/fr/kalydeco-ivacaftor-mucoviscidose
2025
false
false
false
France
infant
treatment outcome
insurance, health, reimbursement
administration, oral
ivacaftor
evaluation of the transparency committee
cystic fibrosis
ivacaftor
---
https://www.has-sante.fr/jcms/p_3576423/fr/pheburane-phenylbutyrate-de-sodium-desordres-du-cycle-de-l-uree
2025
false
false
false
France
pharmaceutical solutions
administration, oral
treatment outcome
insurance, health, reimbursement
sodium phenylbutyrate
4-phenylbutyric acid
carbamoyl-phosphate synthase i deficiency disease
citrullinemia
ornithine carbamoyltransferase deficiency disease
evaluation of the transparency committee
phenylbutyrates
4-phenylbutyric acid, sodium salt
---
https://www.has-sante.fr/jcms/p_3585537/fr/interet-des-techniques-d-amplification-des-acides-nucleiques-taan-multiplex-dans-la-prise-en-charge-medicale-des-infections-neuromeningees
2025
France
health technology assessment
infectious disease, nos
nucleic acid amplification, nos
Infections
nucleic acid amplification techniques
patient care management
---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-clement-boutet
2025
France
audiovisual aids
student, nos
sex
sex ratio
men
france
sexual intercourse, nos
data collection
Pre-Exposure Prophylaxis
hazards models
students
albumin/globulin ratio
proportional hazards models
duration
detective
coitus
french
---
https://www.chu-lyon.fr/deficit-en-alpha-1-antitrypsine-aat
2025
France
popular works
alpha 1-Antitrypsin
aortic aneurysm, thoracic
alpha 1-antitrypsin deficiency
alpha-1-antitrypsin deficiency
---
https://www.chu-lyon.fr/syndrome-dalagille
2025
France
popular works
arteriohepatic dysplasia
alagille syndrome
---
https://www.has-sante.fr/jcms/p_3589534/fr/skyclarys-omaveloxolone-traitement-de-l-ataxie-de-friedreich-af
2025
false
false
false
France
omaveloxolone
evaluation of the transparency committee
friedreich's ataxia
Omaveloxolone
Omaveloxolone
friedreich ataxia
---
https://ansm.sante.fr/tableau-marr/cerliponase-alfa
2025
false
false
false
France
French
guidelines for drug use
risk management
cerliponase alfa
cerliponase alfa
infusions, intracerebroventricular
Movement of device from original site
Device related infection
Device occlusion
infusions, intracerebroventricular
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-du-prelevement-de-cellules-buccales-comme-source-de-materiel-genetique.html
2025
Canada
health technology assessment
genetics
cells
gene pool
mouth, nos
"u" lymphocyte
gene, nos
---
https://www.has-sante.fr/jcms/p_3592928/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine-avec-cardiomyopathie
2025
false
false
false
France
amyloid neuropathies, familial
evaluation of the transparency committee
amylose
amyloidosis, hereditary, Transthyretin-Related
cardiomyopathies
---
https://www.has-sante.fr/jcms/p_3591624/fr/sequencage-haut-debit-cible-des-panels-de-genes-dans-le-diagnostic-des-cardiomyopathies-hereditaires-rapport-d-evaluation
2025
France
health technology assessment
sequence analysis
evaluation studies as topic
diagnosis
genes
sequence determinations
evaluation report
cardiomyopathy, nos
albumin/globulin ratio
no diagnosis
cardiomyopathies
---
https://www.inspq.qc.ca/publications/3595
2025
Canada
public health guidelines
proposita
quebec
west nile virus
west nile virus
organization and administration
virus integration
---
https://www.has-sante.fr/jcms/p_3594999/fr/freestyle-libre-select
2025
France
health technology assessment
persistent
measures
glucose, nos
weights and measures
glucose
breeding
glucose
---
https://www.has-sante.fr/jcms/p_3598534/fr/voxzogo-vosoritide-achondroplasie-chez-les-patients-ages-de-4-mois-a-moins-de-5-ans
2025
false
false
false
France
infant
child
treatment outcome
insurance, health, reimbursement
injections, subcutaneous
vosoritide
evaluation of the transparency committee
vosoritide
achondroplasia
---
https://www.has-sante.fr/jcms/p_3598864/fr/activite-des-techniques-d-amplification-des-acides-nucleiques-simplex-et-multiplex-en-infectiologie-financees-dans-le-cadre-du-rihn
2025
France
health technology assessment
nucleic acid amplification techniques
infectious disease medicine
financial support
nucleic acid amplification, nos
---
https://ansm.sante.fr/tableau-marr/etranacogene-dezaparvovec
2025
false
false
false
France
French
risk management
Etranacogene Dezaparvovec
etranacogene dezaparvovec
guidelines for drug use
patients guideline
popular works
thromboembolism
Drug-Related side effects and adverse reactions
Chemical and Drug Induced Liver Injury
gene therapy
Gene Therapy Agents
semen
blood
DNA-Mediated Gene Transfer
pregnancy
gene transfer, horizontal
---
https://www.has-sante.fr/jcms/p_3601292/fr/principes-d-evaluation-des-techniques-d-amplification-des-acides-nucleiques-taan-multiplex-dans-la-prise-en-charge-medicale-de-pathologies-infectieuses
2025
France
health technology assessment
evaluation studies as topic
communicable diseases
policy
patient care management
principle-based ethics
nucleic acid amplification techniques
nucleic acid amplification, nos
---
https://www.cochrane.org/fr/CD016039/CENTRALED_les-antibiotiques-peuvent-ils-controler-ou-eradiquer-linfection-par-des-mycobacteries-non
2025
United Kingdom
review of literature
french abstract
uncontrolled
cystic fibrosis
antibiotic, nos
tuber, nos
persons
mycobacterium, nos
disease
antibiotics
mycobacterium infections, nontuberculous
lung
infection control
anti-bacterial agents
infectious disease, nos
cystic fibrosis
---
https://publications.msss.gouv.qc.ca/msss/document-002135/
2025
Canada
algorithms
guideline
neonatal screening, nos
patient care management
cystic fibrosis
cystic fibrosis
fibrosis
neonatal screening
---
https://www.has-sante.fr/jcms/p_3602613/fr/libmeldy-atidarsagene-autotemcel-leucodystrophie-metachromatique-30-mois-6-ans
2025
France
evaluation of the transparency committee
leukodystrophy, metachromatic
metachromatic leukodystrophy, nos
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panel-des-syndromes-polymalformatifs-par-sequencage-de-nouvelle-generation.html
2025
Canada
review of literature
generations
abnormalities, multiple
family characteristics
sequence determinations
sequence analysis
---
https://www.has-sante.fr/jcms/p_3536022/fr/sequencage-haut-debit-cible-d-un-panel-de-genes-dans-la-prise-en-charge-medicale-des-tumeurs-stromales-gastro-intestinales-rapport-d-evaluation
2025
false
false
false
France
health technology assessment
Panel Device
Regulatory Report
High Level
Digestive System Neoplasm
Charge
sequence determinations
sequence analysis
Physical Examination
Target Lesion Identification
Target
Nucleic Acid Sequencing
intestinal tract, nos
IPSS-R Risk Category High
Topical Route of Administration
genes
High Mitosis-Karyorrhexis Index
Assessment
albumin/globulin ratio
Backflow
IPSS Risk Category High
High-Frequency Microsatellite Instability
Value Above Reference Range
Ratio
evaluation studies as topic
Topical Dosage Form
Evaluation
Assessment
patient care management
evaluation report
gastrointestinal stromal tumors
Has_Target
Output
---
https://ansm.sante.fr/tableau-marr/lomitapide
2025
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral
---
https://ansm.sante.fr/tableau-acces-derogatoire/upstaza
2025
false
false
false
France
French
Eladocagene Exuparvovec
drug information
infant
Aromatic-L-Amino-Acid decarboxylases
Aromatic-L-Amino-Acid Decarboxylase
aromatic amino acid decarboxylase deficiency
technical report
---
https://ansm.sante.fr/tableau-marr/eladocagene-exuparvovec
2025
false
false
false
France
French
risk management
guidelines for drug use
Eladocagene Exuparvovec
drug compounding
Stereotactic surgery
stereotaxic techniques
gene therapy
Intraputaminal Route of Administration
aromatic amino acid decarboxylase deficiency
Injection of brain (procedure)
infusions, parenteral
neurosurgical procedures
patient education handout
guideline
eladocagene exuparvovec
---
https://www.chu-lyon.fr/education-therapeutique-et-mucoviscidose-age-adulte
2025
France
popular works
age, nos
education
patient education as topic
therapeutics
cystic fibrosis
adulthood
adult
aged
cystic fibrosis
---
https://www.has-sante.fr/jcms/p_3571320/fr/brineura-cerliponase-alfa-maladie-rare
2024
false
false
false
France
evaluation of the transparency committee
cerliponase alfa
cerliponase alfa
disease, nos
Brineura
rare diseases
---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense
---
https://ansm.sante.fr/actualites/fibrinogene-humain-lansm-a-elabore-un-guide-pratique-pour-favoriser-le-bon-usage-des-produits-disponibles
2024
false
false
false
France
French
drug compounding
drug storage
guidelines for drug use
fibrinogen
human fibrinogen
Fibrinogen Human
Product containing only human fibrinogen (medicinal product)
fibrinogen
---
https://www.has-sante.fr/jcms/p_3471037/fr/
2024
France
health technology assessment
genome, nos
Early Stage Breast Carcinoma
breast cancer
Useful
hospitals, proprietary
Clinical Data
Signature
Genome
early
Clinical Lot
breast neoplasms
Ambulatory Care Facility
neoplasm staging
genomics
Clinical Batch
genome
neoplasm, malignant
---
https://www.has-sante.fr/jcms/p_3478096/fr/kalydeco-ivacaftor-mucoviscidose
2024
false
false
false
France
infant
child
evaluation of the transparency committee
ivacaftor
cystic fibrosis
ivacaftor
Ivacaftor
Cystic Fibrosis
cystic fibrosis
kalydeco
ivacaftor
---
https://ansm.sante.fr/tableau-marr/inhibiteur-de-la-c1-esterase-humaine
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
Human C1-Esterase Inhibitor
patients guideline
---
https://www.usherbrooke.ca/baladocritique/archives/episode-59-etude-select
2024
Canada
sound
Diastolic Blood Pressure
semaglutide
Obesity, CTCAE
Cardiovascular Disorder
data collection
Off Study
obesity
disease of cardiovascular system, nos
breeding
Clinical Study
semaglutide
obesity
Obesity
Have Diabetes
Human Participant Protection Regulations
DICOM Study
obesity, nos
cardiovascular diseases
diabetes mellitus
persons
Semaglutide
Obese
On Study
---
https://www.has-sante.fr/jcms/p_3490824/fr/crysvita-burosumab-hypophosphatemie-liee-a-l-x
2024
false
false
false
France
child
adolescent
treatment outcome
insurance, health, reimbursement
rickets, X-Linked hypophosphatemic
burosumab
injections, subcutaneous
antibodies, monoclonal, humanized
evaluation of the transparency committee
burosumab
familial hypophosphatemic rickets
X-Linked Dominant Hypophosphatemic Rickets
---
https://www.has-sante.fr/jcms/p_3426280/fr/depistage-neonatal-reevaluation-de-l-opportunite-d-integrer-cinq-erreurs-innees-du-metabolisme-au-programme-de-dnn
2024
France
public health guidelines
Newborn Screening
Schedule
metabolic disease, nos
Integrator Device
Integrated
neonatal screening, nos
metabolism, inborn errors
neonatal screening
Severity One Out of Five
Congenital Metabolic Disorder
Scheduled
Metabolic Programming
---
https://publications.msss.gouv.qc.ca/msss/document-003344/
2024
false
false
false
Canada
handbooks
hereditary diseases
Diseases
metabolic diseases
metabolism, inborn errors
Metabolic diseases
Hereditary disease
Metabolic diseases
Metabolic diseases
metabolic disease, nos
Program
hereditary disease, nos
waiting lists
---
https://ansm.sante.fr/tableau-acces-derogatoire/oxbryta-voxelotor
2024
false
false
false
France
French
risk management
voxelotor
voxelotor
administration, oral
hematologic agents
drug information
anemia, hemolytic
anemia, sickle cell
Safety-Based drug withdrawals
---
https://www.cochrane.org/fr/CD002203/CF_traitement-par-antibiotiques-macrolides-y-compris-lazithromycine-pour-les-personnes-atteintes-de
2024
false
true
false
United Kingdom
France
treatment outcome
azithromycin
infant, newborn
adult
child
pseudomonas aeruginosa
pseudomonas infections
meta-analysis
french abstract
macrolides
cystic fibrosis
anti-bacterial agents
---
http://publications.msss.gouv.qc.ca/msss/document-000179/
2024
false
false
false
false
Canada
French
scientific and technical information
resulting in
genes
physicians
hemoglobinopathies
carrier state, nos
hemoglobinopathy, nos
Handbook
interpreter
Handbook
---
https://ansm.sante.fr/tableau-marr/acitretine
2024
false
false
false
France
French
guidelines for drug use
patients guideline
risk management
teratogens
continuity of patient care
acitretin
acitretin
pregnancy
contraception
administration, oral
acitretin
mental disorders
drug monitoring
Chemical and Drug Induced Liver Injury
pancreatitis
psoriasis
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/valproate-et-derives
2024
false
false
false
France
French
risk management
valproate
pregnancy
teratogens
valproate sodium
-
Divalproex Sodium
dipropylacetamide
pregnancy tests
contraception
guideline
patient education handout
forms
developmental disabilities
Contraindications, Drug
valproic acid
valproic acid
---
https://www.inspq.qc.ca/publications/3590
2024
Canada
technical report
organizations
reference values
organ part
Organisms Category
methods
toxicology
research
breeding
threshold limit values
---
https://ansm.sante.fr/tableau-marr/topiramate
2024
false
false
false
France
French
risk management
Topiramate
teratogens
abnormalities, drug-induced
guideline
guidelines for drug use
patient education handout
Neurodevelopmental Disorders
prenatal exposure delayed effects
pregnancy
Autism Spectrum Disorder
contraception
female
adolescent
adult
Female of Childbearing Potential
fetus
---
https://ansm.sante.fr/tableau-marr/agalsidase-alpha
2024
false
false
false
France
French
risk management
agalsidase alfa
agalsidase alfa
infusions, intravenous
guidelines for drug use
patients guideline
continuity of patient care
drug hypersensitivity
self administration
---
https://ansm.sante.fr/tableau-marr/laronidase
2024
false
false
false
France
French
risk management
Laronidase
infusions, intravenous
drug hypersensitivity
home nursing
guidelines for drug use
patients guideline
laronidase
home infusion therapy
Infusion-Related Reaction
---
https://www.chu-lyon.fr/hyperplasie-congenitale-des-surrenales
2024
France
patient education handout
adrenal hyperplasia, congenital
Hypotonia-Cystinuria syndrome
congenital adrenal cortical hyperplasia, nos
---
https://www.ameli.fr/sites/default/files/Documents/20241213-topiramate-brochure-information-patientes-1.pdf
2024
France
patient education handout
child
nuclear family
adolescent
generations
daughters
pregnancy, nos
emigration and immigration
child, nos
Epitomax
adolescence
pamphlets
adolescents, female
Topiramate
Pregnant People
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-de-lajout-du-depistage-neonatal-de-lhyperplasie-congenitale-des-surrenales-au-programme-quebecois-de-depistage-neonatal-sanguin.html
2024
Canada
review of literature
public health guidelines
Add
Attention Deficit Hyperactivity Disorder, Inattentive Type
Schedule
congenital adrenal cortical hyperplasia, nos
adrenal hyperplasia, congenital
Program
neonatal screening, nos
Newborn Screening
neonatal screening
Congenital Adrenal Hyperplasia
Blood Screening
Scheduled
---
https://www.has-sante.fr/jcms/p_3449778/fr/crysvita-burosumab-hypophosphatemie-liee-au-fgf23
2024
false
false
false
France
French
evaluation of the transparency committee
burosumab
---
https://www.has-sante.fr/jcms/p_3495394/fr/takhzyro-lanadelumab-angioedeme-hereditaire
2024
false
false
false
France
French
insurance, health, reimbursement
lanadelumab
evaluation of the transparency committee
child
angioedemas, hereditary
Hereditary angioedema attack
lanadelumab
treatment outcome
guidelines for drug use
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release
solution for injection (clinical drug)
---
https://www.has-sante.fr/jcms/p_3498146/fr/myozyme-alglucosidase-alfa-maladie-de-pompe-deficit-en-glucosidase-acide
2024
false
false
false
France
GAA protein, human
adult
adolescent
child
treatment outcome
insurance, health, reimbursement
enzyme replacement therapy
infusions, intravenous
alglucosidase alfa
glycogen storage disease type II, infantile
adult glycogen storage disease type II
Glycogen storage disease type II late onset (disorder)
evaluation of the transparency committee
glycogen storage disease type ii
alglucosidase alfa
---
https://www.has-sante.fr/jcms/p_3498741/fr/takhzyro-lanadelumab-angiooedeme-hereditaire
2024
false
false
false
France
antibodies, monoclonal, humanized
treatment outcome
insurance, health, reimbursement
angioedemas, hereditary
child
lanadelumab
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release
solution for injection (clinical drug)
Hereditary angioedema attack
evaluation of the transparency committee
lanadelumab
---
https://publications.msss.gouv.qc.ca/msss/document-003698/
2024
Canada
scientific and technical information
algorithms
genets
genetics
gene, nos
Clinical Trial Eligibility Criteria
mars
Genetic Testing
Handbook
insurance
Interpretation
genetta, nos
cytisus
interpreter
Department
March
Software Service
Guide Device
viverridae
Algorithm
---
https://www.has-sante.fr/jcms/p_3499784/fr/prolastin-alpha-1-antitrypsine-humaine-deficit-en-alpha-1-antitrypsine
2024
false
false
false
France
insurance, health, reimbursement
alfa1 antitrypsin
alpha 1-Antitrypsin
alpha 1-antitrypsin deficiency
Product containing only human alpha1 proteinase inhibitor in parenteral dose form
(medicinal product form)
evaluation of the transparency committee
---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related
---
https://www.health.belgium.be/fr/avis-9801-nouvelles-techniques-genomiques-ngts
2024
Belgium
technical report
Tumor Necrosis Factor Ligand Superfamily Member 15
proposita
Middle
genome, nos
Moderately Bothered
Medium Heart Murmur
genome
Some
Adverse Event Definitely Related to Intervention
A Medium Amount of Time
Middle Lobe of the Prostate
Medium Growth Rate
plants
Technique
Genome
social control, formal
Media
genomics
Proposal
TNFSF15 wt Allele
Certain
Growth Medium
---
https://ansm.sante.fr/actualites/decision-du-21-03-2024-cadre-de-prescription-compassionnelle-de-tacrolimus-0-1-pommade
2024
false
false
false
France
French
drug information
tacrolimus
administration, cutaneous
ointments
legislation, pharmacy
adult
child
adolescent
vitiligo
tacrolimus
---
https://ansm.sante.fr/tableau-acces-derogatoire/tacrolimus#
2024
false
false
false
France
French
tacrolimus
drug information
administration, cutaneous
vitiligo
---
Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous
Adverse Reactions
https://recalls-rappels.canada.ca/fr/avis-rappel/ezetrol-ezetimibe-et-risques-lesions-hepatiques-origine-medicamenteuse-et-reactions
2024
false
false
false
Canada
French
English
pharmacovigilance note
Ezetimibe
Chemical and Drug Induced Liver Injury
Drug-Induced Liver Disease
drug hypersensitivity syndrome
stevens-johnson syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
canada
administration, oral
ezetimibe
anticholesteremic agents
---
https://www.has-sante.fr/jcms/p_3505740/fr/lojuxta-lomitapide-hypercholesterolemie-familiale-homozygote
2024
false
false
false
France
Lomitapide Mesylate
Homozygous Familial Hypercholesterolemia
child
adolescent
evaluation of the transparency committee
lomitapide
Lomitapide Mesylate
mesylates
---
https://www.reseau-naissance.fr/medias/2016/12/Protocole-PEC-nne-de-mere-sous-opiaces-pendant-la-grossesse.pdf
2024
France
guideline
opioid withdrawal
newborn, nos
New Lesion Identification
Newar Language
infant, newborn
health planning guidelines
charge association
CHARGE Syndrome
mother, nos
Maternal
Maternal Relative
patient care management
CHARGE syndrome
substance withdrawal syndrome
Opiate Withdrawal Syndrome
---
https://www.has-sante.fr/jcms/p_3471694/fr/orkambi-lumacaftor/ivacaftor-mucoviscidose
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
lumacaftor, ivacaftor drug combination
drug combinations
ivacaftor
lumacaftor
ivacaftor and lumacaftor
infant
administration, oral
evaluation of the transparency committee
cystic fibrosis
---
https://www.irsst.qc.ca/publications-et-outils/publication/i/101204/n/exposition-professionnelle-femmes-substances-chimiques
2024
Canada
technical report
effects of exposure to external cause, nos
Specified
Chemical Exposure
C-C Motif Chemokine 7
Matrix Device
Substance
Fogarty International Center
Be
Enhance
Gender
employment
specific
CDISC SDTM Sex of Individual Terminology
unemployment
sex ratio
Ratio
templates, genetic
albumin/globulin ratio
Improved
Designated
extracellular matrix
occupational exposure
sex
women
GDC Gender Terminology
Regulatory Report
Statistical Estimation
Matrix Dosing Unit
Unemployed
CCL7 wt Allele
Provide
Occupational Exposure
Respect
Abstracting
Fentanyl
appraiser
Designated Blood Product Donation
Estimate
Woman
---
https://www.has-sante.fr/jcms/p_3516966/fr/loargys-pegzilarginase-deficit-en-arginase-1
2024
false
false
false
France
ARG1 protein, human
insurance, health, reimbursement
treatment outcome
orphan drug production
package leaflet
summary of product characteristics
adult
pegzilarginase
adolescent
child
guidelines for drug use
enzyme replacement therapy
continuity of patient care
evaluation of the transparency committee
hyperargininemia
Arginase-1
Pegzilarginase
---
https://www.ema.europa.eu/en/medicines/human/EPAR/loargys
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Pegzilarginase
Pegzilarginase
pegzilarginase
enzyme replacement therapy
drug approval
europe
hyperargininemia
orphan drug production
child
adolescent
adult
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
infusions, intravenous
injections, subcutaneous
---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024005/article/00002-fra.htm
2024
Canada
technical report
Choose
Survey
Inquiry
Surveys and Questionnaires
Assessment
Evaluation
Investigation
breeding
calculi
weights and measures
Physical Examination
Calculation
Assessment
allostasis
health
detective
Charge
protestantism
allostatic load
How was the Extent of Disease Measured
Selenium and Vitamin E Efficacy Trial
measures
evaluation studies as topic
---
https://www.has-sante.fr/jcms/p_3517566/fr/kaftrio-ivacaftor/tezacaftor/elexacaftor-en-association-avec-kalydeco-ivacaftor-mucoviscidose-de-2-ans-a-moins-de-6-ans
2024
false
false
false
France
child
treatment outcome
insurance, health, reimbursement
drug combinations
drug therapy, combination
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor
tezacaftor
ivacaftor
ivacaftor, tezacaftor and elexacaftor
administration, oral
evaluation of the transparency committee
cystic fibrosis
ivacaftor
---
https://www.has-sante.fr/jcms/p_3517166/fr/genotonorm-somatropine-hormone-de-croissance
2024
false
false
false
France
failure to thrive
evaluation of the transparency committee
Somatropin
hormone, nos
human growth hormone
growth hormone
Somatotropin
---
https://ansm.sante.fr/tableau-acces-derogatoire/onpattro
2024
false
false
false
France
French
patisiran
drug information
guidelines for drug use
infusions, intravenous
Wild type ATTR amyloidosis
Hereditary ATTR amyloidosis
Cardiac ATTR Amyloidosis
amyloidosis
Transthyretin
---
https://www.has-sante.fr/jcms/p_3518649/fr/ilaris-canakinumab-crise-d-arthrite-goutteuse
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Acute gout (disorder)
canakinumab
injections, subcutaneous
evaluation of the transparency committee
canakinumab
arthritis, gouty
---
https://pap-pediatrie.fr/endocrinologie/variations-isolees-du-developpement-genital-en-maternite
2024
France
scientific and technical information
algorithms
Development Batch
hospitals, maternity
motherhood
genetic variation
Genital
Development Lot
variant
Maturation
genital system, nos
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/detection-de-la-mutation-d816v-du-gene-kit-par-taan.html
2024
Canada
health technology assessment
KIT Gene
gene, nos
Embarrassment
KIT Gene Mutation
genes
detective
Mutation Detection
KIT NP_000213.1:p.D816V
nucleic acid amplification techniques
Nucleic Acid Amplification Test
mutation
---
https://www.cochrane.org/fr/CD009530/CF_utilisation-dechantillons-obtenus-par-bronchoscopie-pour-decider-comment-traiter-les-infections
2024
United Kingdom
review of literature
french abstract
People
bronchoscopy
persons
Bronchoscopy
Infectious Lung Disorder
cystic fibrosis
Cystic Fibrosis
Infections
specimen processing, nos
pulmonary cystic fibrosis
cystic fibrosis of the lung
Specimen Processing
infectious disease, nos
medical waste disposal
bronchoscopy, nos
disease
Use
---
https://www.ema.europa.eu/en/medicines/human/EPAR/skyclarys
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Omaveloxolone
Omaveloxolone
drug approval
europe
orphan drug production
friedreich ataxia
continuity of patient care
administration, oral
product surveillance, postmarketing
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
omaveloxolone
---
https://www.has-sante.fr/jcms/p_3529879/fr/depakine-micropakine-depakine-chrono-depakote-depamide-valproate-de-sodium-valproate-de-sodium/acide-valproique-divalproate-de-sodium-valpromide-epilepsie-et-troubles-bipolaires
2024
false
false
false
France
-
insurance, health, reimbursement
treatment outcome
anticonvulsants
valproic acid
administration, oral
valpromide
evaluation of the transparency committee
Divalproex Sodium
epilepsy
bipolar disorder
dipropylacetamide
valproic acid
valproate sodium
---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/pneumologie-cardiologie/specificites-maladies-genetiques-propos-dune-maladie-genique-mucoviscidose
2024
France
educational course
Cystic Fibrosis
disease, nos
No Evidence of Coronary Artery Disease
sensitivity and specificity
cystic fibrosis
cystic fibrosis
genetics
Disease Steps Clinical Classification
Specificity of Diagnostic Test
disease
specificity
proband
Disease Free
Disease Object
Approximate
genets
Analyte Specificity
hereditary disease, nos
---
https://ansm.sante.fr/dossiers-thematiques/topiramate-et-grossesse
2024
false
false
false
France
French
Topiramate
pregnancy
patients guideline
epilepsy
migraine disorders
Topiramate
guideline
risk
abnormalities, drug-induced
In Utero Drug Exposure
Female of Childbearing Potential
topiramate
---
https://www.has-sante.fr/jcms/p_3535386/fr/sequencage-haut-debit-cible-d-un-panel-de-genes-dans-la-prise-en-charge-medicale-du-cancer-du-poumon-recherche-des-alterations-moleculaires-somatiques
2024
France
health technology assessment
Impairment
IPSS Risk Category High
lung neoplasms
sequence determinations
Has_Target
Nucleic Acid Sequencing
Topical Route of Administration
Output
Value Above Reference Range
Cancer Research
Lung Carcinoma
neoplasm, malignant
Cancer Burden
medical research
Backflow
Somatic
Topical Dosage Form
Molecular
genes
Panel Device
IPSS-R Risk Category High
biomedical research
High-Frequency Microsatellite Instability
Alteration
Target
lung cancer
sequence analysis
High Level
High Mitosis-Karyorrhexis Index
Target Lesion Identification
patient care management
---
https://www.has-sante.fr/jcms/p_3536003/fr/sequencage-haut-debit-cible-d-un-panel-de-genes-dans-la-prise-en-charge-medicale-de-la-leucemie-lymphoide-chronique-rapport-d-evaluation
2024
France
health technology assessment
leukemia, lymphocytic, chronic, B-Cell
IPSS-R Risk Category High
Physical Examination
Has_Target
NCI CTEP SDC Chronic Lymphoid Leukemia Sub-Category Terminology
albumin/globulin ratio
Target
evaluation report
patient care management
sequence analysis
Panel Device
leukemia, lymphoid
Output
High Level
Assessment
Target Lesion Identification
genes
leukaemia
Topical Dosage Form
Assessment
sequence determinations
chronic lymphocytic leukemia
IPSS Risk Category High
High Mitosis-Karyorrhexis Index
Topical Route of Administration
Evaluation
Charge
Ratio
Backflow
Chronic Lymphocytic Leukemia
High-Frequency Microsatellite Instability
Regulatory Report
Value Above Reference Range
evaluation studies as topic
Nucleic Acid Sequencing
---
https://www.has-sante.fr/jcms/p_3536272/fr/principes-d-evaluation-des-actes-de-sequencage-haut-debit-cible-panels-de-genes-en-genetique-somatique-des-cancers
2024
France
health technology assessment
genes
genes, neoplasm
Genetic Target
evaluation studies as topic
sequence analysis
Assay Target Antigen
policy
Nucleic Acid Sequencing
genetics
High Level
gene, nos
Value Above Reference Range
IPSS-R Risk Category High
Biopolymer Sequencing
principle-based ethics
Backflow
Somatic
IPSS Risk Category High
sequence determinations
High-Frequency Microsatellite Instability
High Mitosis-Karyorrhexis Index
Topical Dosage Form
Panel Device
Topical Route of Administration
Output
Gene
---
https://www.has-sante.fr/jcms/p_3536492/fr/activite-du-sequencage-haut-debit-cible-en-genetique-somatique-des-cancers-financee-dans-le-cadre-du-rihn-programme-des-evaluations-des-actes-de-sequencage-haut-debit-cible
2024
France
health technology assessment
sequence analysis
FDA Establishment Activity Terminology
Biochemical Activity
Somatic
Active
Topical Route of Administration
Scheduled
Assay Target Antigen
financial support
gene, nos
IPSS Risk Category High
Genetic Target
Schedule
Value Above Reference Range
Backflow
Topical Dosage Form
IPSS-R Risk Category High
Biopolymer Sequencing
program evaluation
High Mitosis-Karyorrhexis Index
Nucleic Acid Sequencing
sequence determinations
genetics
High Level
High-Frequency Microsatellite Instability
Funding
Output
CDISC SDTM Environmental Setting Terminology
---
https://www.has-sante.fr/jcms/p_3536496/fr/activite-du-sequencage-haut-debit-cible-en-genetique-somatique-des-cancers-financee-dans-le-cadre-du-rihn
2024
France
technical report
High Level
Somatic
Genetic Target
Nucleic Acid Sequencing
CDISC SDTM Environmental Setting Terminology
Topical Route of Administration
Funding
sequence analysis
IPSS-R Risk Category High
High Mitosis-Karyorrhexis Index
gene, nos
Backflow
Active
IPSS Risk Category High
Output
Biopolymer Sequencing
Value Above Reference Range
High-Frequency Microsatellite Instability
sequence determinations
Topical Dosage Form
genetics
Biochemical Activity
financial support
FDA Establishment Activity Terminology
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panel-des-maladies-mitochondriales-par-sequencage-de-nouvelle-generation.html
2024
Canada
technical report
family characteristics
disease, nos
Panel Device
generations
mitochondrial diseases
sequence analysis
Next Generation Sequencing
sequence determinations
Mitochondrion
mitochondrion, nos
Disease or Disorder
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/principes-et-criteres-permettant-de-baliser-le-recours-au-sequencage-pangenomique-par-rapport-au-sequencage-cible-dun-nombre-limite-de-genes-pour-la-recherche-de-variants-germinaux.html
2024
Canada
technical report
policy
sequence analysis
Limited Lifting Ability
Limited
genes
Has_Target
Criterion
Limited Walking Ability
Number
albumin/globulin ratio
Target
research report
medical futility
principle-based ethics
Ratio
Target Lesion Identification
Regulatory Report
Nucleic Acid Sequencing
sequence determinations
---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024008/article/00001-fra.htm
2024
Canada
technical report
Socioeconomics
Correlation
canada
life expectancy
Submission Domain
CDISC SDTM Submission Domain Abbreviation Terminology
Life
united states
Vietnamese Language
Laser-Induced Fluorescence Endoscopy
genetic variation
VIE Regimen
variant
---
https://ansm.sante.fr/tableau-marr/pegzilarginase
2024
false
false
false
France
French
risk management
Pegzilarginase
pegzilarginase
drug information
patients guideline
medication errors
Pegzilarginase
drug hypersensitivity
injections, subcutaneous
home nursing
---
https://www.canal-u.tv/chaines/univ-bordeaux/deficit-en-alpha-1-antitrypsine
2024
France
audiovisual aids
alpha 1-antitrypsin deficiency
alpha-1-antitrypsin deficiency
Alpha-1 Antitrypsin Deficiency
---
https://www.has-sante.fr/jcms/p_3538246/fr/luxturna-voretigene-neparvovec-dystrophie-retinienne-hereditaire
2024
false
false
false
France
voretigene neparvovec
treatment outcome
insurance, health, reimbursement
adult
child
adolescent
vision disorders
evaluation of the transparency committee
retinal dystrophies
Hereditary Retinal Dystrophy
Voretigene Neparvovec
---
https://www.has-sante.fr/jcms/p_3538948/fr/siklos-hydroxycarbamide-drepanocytose
2024
false
false
false
France
evaluation of the transparency committee
hydroxyurea
hydroxyurea
hemoglobin s disease
anemia, sickle cell
---
https://www.has-sante.fr/jcms/p_3539069/fr/ilaris-canakinumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
canakinumab
injections, subcutaneous
chronic disease
biological therapy
---
https://www.has-sante.fr/jcms/p_3542845/fr/skyclarys-omaveloxolone-ataxie-de-friedreich
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
adolescent
administration, oral
orphan drug production
omaveloxolone
evaluation of the transparency committee
friedreich ataxia
Omaveloxolone
---
https://www.has-sante.fr/jcms/p_3542903/fr/paraparesies-spastiques-hereditaires-pures
2024
France
practice guideline
Handbook
hereditary diseases
chronic disease, nos
chronic disease
paraparesis
genetic diseases, inborn
spasm, nos
hereditary disease, nos
paraparesis, spastic
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panel-des-erreurs-innees-de-limmunite-par-sequencage-de-nouvelle-generation.html
2024
Canada
technical report
achievement
evaluation studies as topic
family characteristics
sequence analysis
quebec
generations
sequence determinations
evaluation report
immune state, nos
immunity, innate
albumin/globulin ratio
---
https://www.irsst.qc.ca/publications-et-outils/video/i/100543/n/boite-gants-outil-selection-gants-protection
2024
Canada
video recording
breeding
claudication
gloves, protective
tool, nos
---
https://ansm.sante.fr/informations-de-securite/oxbryta-voxelotor-suspension-de-lautorisation-de-mise-sur-le-marche-de-lunion-europeenne
https://ansm.sante.fr/actualites/oxbryta-voxelotor-conduite-a-tenir-suite-a-la-suspension-de-lautorisation-de-mise-sur-le-marche
2024
false
false
false
France
French
Safety-Based drug withdrawals
voxelotor
pharmacovigilance note
voxelotor
guidelines for drug use
drugs, investigational
france
europe
hematologic agents
Vaso-Occlusive Crisis
---
https://www.has-sante.fr/jcms/p_3552796/fr/kaftrio-ivacaftor-/-tezacaftor-/-elexacaftor-en-association-avec-kalydeco-ivacaftor-mucoviscidose-enfant-6-ans
2024
false
false
false
France
drug therapy, combination
drug combinations
treatment outcome
insurance, health, reimbursement
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
tezacaftor
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance
regulator gene
CFTR delta F508
ivacaftor, tezacaftor and elexacaftor
ivacaftor
administration, oral
evaluation of the transparency committee
elexacaftor
child
cystic fibrosis
---
https://www.has-sante.fr/jcms/p_3554673/fr/nexviadyme-avalglucosidase-alfa-maladie-de-pompe
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Avalglucosidase Alfa
avalglucosidase alfa
enzyme replacement therapy
guidelines for drug use
evaluation of the transparency committee
glycogen storage disease type ii
---
https://www.has-sante.fr/jcms/p_3550922/fr/crysvita-burosumab-maladie-osseuse
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
burosumab
FGF23-related hypophosphataemia
hypophosphatemia
X-linked hypophosphatemia
child
adolescent
adult
Oncogenic hypophosphatemic osteomalacia
Phosphaturic Mesenchymal Tumor
evaluation of the transparency committee
burosumab
bone diseases
---
https://www.yearbook-ers.jle.com/e-docs/variations_spatiotemporelles_de_lincidence_du_diabete_de_type_1_chez_lenfant_et_liens_avec_des_facteurs_geographiques_environnementaux_351936/yb_synthese.phtml
2024
France
journal article
geographer
geography
child, nos
genetic variation
child
geographic factors
environment
diabetes mellitus, type 1
postman
incidence
variant
---
https://www.has-sante.fr/jcms/p_3555789/fr/libmeldy-atidarsagene-autotemcel-leucodystrophie-metachromatique-ldm
2024
false
false
false
France
Atidarsagene Autotemcel
insurance, health, reimbursement
treatment outcome
gene therapy
arylsulfatase A deficiency
ARSA Gene Mutation
metachromatic leukodystrophy, infant
leukodystrophy, metachromatic, juvenile
child
atidarsagene autotemcel
infusions, intravenous
evaluation of the transparency committee
leukodystrophy, metachromatic
---
https://www.has-sante.fr/jcms/p_3557049/fr/interet-des-techniques-d-amplifications-des-acides-nucleiques-taan-multiplex-dans-la-prise-en-charge-medicale-des-infections-gastro-intestinales
2024
France
health technology assessment
intestines
nucleic acid amplification techniques
intestinal tract, nos
nucleic acid amplification, nos
patient care management
gastrointestinal infection
Infections
infectious disease, nos
---
https://www.has-sante.fr/jcms/p_3558113/fr/programme-des-evaluations-des-techniques-d-amplification-des-acides-nucleiques-taan-en-infectiologie-financees-dans-le-cadre-du-rihn
2024
France
health technology assessment
nucleic acid amplification techniques
financial support
infectious disease medicine
program evaluation
nucleic acid amplification, nos
---
https://www.cbip.be/fr/articles/4448?folia=4434
2024
false
false
false
Belgium
French
pharmacovigilance note
journal article
cyclosporine
risk
fibroadenoma
premenopause
---
https://publications.msss.gouv.qc.ca/msss/document-003841/
2024
Canada
handbooks
gene, nos
genetta, nos
filiation
case histories
genetics
family
viverridae
genets
biology
cytisus
biology
medical history taking
---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2024-50/numero-12-decembre-2024/pseudo-eclosion-mycobacterium-tuberculosis-contamination-croisee-laboratoire.html
2024
Canada
journal article
hybridization, genetic
due to
mycobacterium tuberculosis
pseudotuberculosis
research personnel
mycobacterium tuberculosis hominis
tuberculosis
molecular epidemiology
laboratories
---
https://www.cochrane.org/fr/CD001401/CF_techniques-de-degagement-des-voies-respiratoires-comparees-labsence-de-techniques-de-degagement-des
2023
false
France
United Kingdom
French
review of literature
cystic fibrosis
respiratory therapy
treatment outcome
french abstract
---
https://www.filiere-g2m.fr/documentation/publication/187:protocole-d-urgence-coma-et-maladies-hereditaires-du-metabolisme
2023
France
algorithms
metabolism, inborn errors
hereditary diseases
On Study
coma
emergencies
Genetic Disorder
Emergency Room
coma, nos
metabolic diseases
Emergency
coma
hereditary disease, nos
Coma
metabolic disease, nos
Urgency
Clinical Study Protocol
Metabolic Disorder
---
https://www.sfm-microbiologie.org/wp-content/uploads/2023/06/Recommandations-geenotypage-V1_2023-06-12.pdf
2023
France
practice guideline
SARS-CoV-2
suggestive of
health planning guidelines
sequence determinations
indication of
viruses
sequence analysis
indicators and reagents
genetic fingerprinting
virus, nos
DNA fingerprinting
---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-5-mai-2023/comparaison-tests-utilises-programme-sras-cov-2-rcli.html
2023
Canada
journal article
nucleic acids
nucleic acid amplification, nos
reticulum
competence
nucleic acid amplification techniques
mental competency
Program
Nucleic acids
Severe acute respiratory syndrome-related coronavirus
auditor
competence
laboratories
---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-5-mai-2023/tests-aptitude-sras-cov-2-reseau-canadien-intervention-laboratoire.html
2023
Canada
journal article
canada
laboratories
Essay
reticulum
Severe acute respiratory syndrome-related coronavirus
Program
nucleic acids
Nucleic acids
patient compliance
nucleic acid amplification techniques
aptitude
nucleic acid amplification, nos
observation
---
https://www.has-sante.fr/jcms/p_3444027/fr/hemgenix-etranacogene-dezaparvovec-hemophilie-b
2023
false
false
false
France
adult
treatment outcome
Etranacogene Dezaparvovec
genetic therapy
hemophilia B
etranacogene dezaparvovec
evaluation of the transparency committee
hemophilia B
---
https://www.ema.europa.eu/en/medicines/human/EPAR/hemgenix
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Etranacogene Dezaparvovec
Etranacogene Dezaparvovec
etranacogene dezaparvovec
gene therapy
orphan drug production
adult
hemophilia B
hemorrhage
infusions, intravenous
factor IX
F9 Gene
product surveillance, postmarketing
drug interactions
pregnancy
drug evaluation, preclinical
---
https://www.ema.europa.eu/en/medicines/human/EPAR/pombiliti
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Cipaglucosidase Alfa
Cipaglucosidase Alfa
cipaglucosidase alfa
enzyme replacement therapy
glycogen storage disease type ii
Glycogen storage disease type II late onset (disorder)
drug therapy, combination
miglustat
infusions, intravenous
pregnancy
breast feeding
drug evaluation, preclinical
adult
---
https://www.cochrane.org/fr/CD002011/CF_la-kinesitherapie-respiratoire-conventionnelle-classique-comparee-dautres-methodes-de-degagement-des
2023
United Kingdom
review of literature
french abstract
respiratory system
Other methods
disease
cystic fibrosis
cystic fibrosis
Cystic fibrosis
protestantism
respiratory tract
physical therapy specialty
persons
---
https://www.has-sante.fr/jcms/p_3312530/fr/diagnostic-et-prise-en-charge-des-patients-adultes-avec-un-syndrome-post-reanimation-pics-et-de-leur-entourage
2023
France
practice guideline
adulthood
charge association
resuscitation
no diagnosis
case management
diagnosis
CHARGE syndrome
Adult
Propping Zerres syndrome
Adult
has patient
adult
CHARGE syndrome
propping zerres syndrome
---
https://www.has-sante.fr/jcms/p_3448025/fr/oxbryta-voxelotor-anemie-hemolytique
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
voxelotor
hematologic agents
anemia, sickle cell
adult
adolescent
summary of product characteristics
drug therapy, combination
evaluation of the transparency committee
voxelotor
anemia, hemolytic
---
https://www.has-sante.fr/jcms/p_3385532/fr/voxzogo-0-4-0-56-1-2-mg-vosoritide-achondroplasie
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
vosoritide
child
adolescent
evaluation of the transparency committee
achondroplasia
vosoritide
---
https://www.has-sante.fr/jcms/p_3446078/fr/diprosone-betamethasone-/-diprosalic-betamethasone-/-acide-salicylique-corticoides
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
administration, cutaneous
evaluation of the transparency committee
salicylic acid
corticoids
betamethasone
glucocorticoids
---
http://www.lecrat.eu/?s=Canakinumab+-+Grossesse+et+allaitement
2023
false
false
false
France
French
drug information
pregnancy
breast feeding
canakinumab
---
https://www.has-sante.fr/jcms/p_3448570/fr/vimizim-elosulfase-alfa-mucopolysaccharidose-de-type-iv-a-syndrome-de-morquio-a
2023
false
false
false
France
infusions, intravenous
treatment outcome
insurance, health, reimbursement
elosulfase alfa
mucopolysaccharidosis type IV A
enzyme replacement therapy
evaluation of the transparency committee
mucopolysaccharidosis IV
elosulfase alfa
---
https://ansm.sante.fr/actualites/lamotrigine-attention-au-risque-deruption-cutanee-grave-en-particulier-au-debut-du-traitement
2023
false
false
false
France
French
pharmacovigilance note
Lamotrigine
lamotrigine
drug eruptions
administration, oral
anticonvulsants
antipsychotic agents
drug hypersensitivity syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
guidelines for drug use
---
https://ansm.sante.fr/tableau-acces-derogatoire/crysvita
2023
false
false
false
France
French
drug information
burosumab
burosumab
FGF23-related hypophosphataemia
Oncogenic hypophosphatemic osteomalacia
hypophosphatemia
---
http://beh.santepubliquefrance.fr/beh/2023/12-13/2023_12-13_2.html
2023
France
journal article
inpatients
France
crisis, nos
Cancer
incidence
neoplasms
France
cancer
france
COVID-19
french
variant
France
has patient
France
neoplasm, malignant
hospital admission, nos
genetic variation
evaluation studies as topic
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/prolastinmc-c-liquid-deficit-congenital-en-alpha1-antitrypsine.html
2023
Canada
drug evaluation
alpha 1-Antitrypsin
prolastin
liquid substance, nos
---
https://www.ema.europa.eu/en/medicines/human/EPAR/opfolda
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
miglustat
miglustat
miglustat
drug approval
europe
adult
Glycogen storage disease due to acid maltase deficiency, late-onset
adult glycogen storage disease type II
drug therapy, combination
Cipaglucosidase Alfa
administration, oral
capsules
aged
food-drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
---
https://ansm.sante.fr/informations-de-securite/valproate-et-derives-risque-potentiel-de-troubles-neurodeveloppementaux-chez-les-enfants-dont-le-pere-a-ete-traite-dans-les-3-mois-qui-precedent-la-conception
2023
false
false
false
France
French
pharmacovigilance note
Divalproex Sodium
Neurodevelopmental Disorders
Male
risk
risk assessment
fathers
infant
child
Perinatal Exposure
paternal exposure
valproic acid
valproate sodium
teratogens
---
https://www.cochrane.org/fr/CD004197/CF_differentes-manieres-dadministrer-des-antibiotiques-pour-eliminer-une-infection-pseudomonas
2023
United Kingdom
review of literature
french abstract
organization and administration
cystic fibrosis
administration
pseudomonas aeruginosa
Administration
administration of antibiotic
Infectious disease
infection due to pseudomonas aeruginosa
Antibiotics
antibiotics
administrators
pseudomonas infections
mannerism
Cystic fibrosis
disease
cystic fibrosis
administrative personnel
anti-bacterial agents
persons
Pseudomonas aeruginosa Infection
---
https://www.has-sante.fr/jcms/p_3402366/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine
2023
false
false
false
France
vutrisiran
treatment outcome
insurance, health, reimbursement
Vutrisiran
rna, small interfering
injections, subcutaneous
adult
RNAi Therapeutics
amyloid neuropathies, familial
evaluation of the transparency committee
amyloidosis, hereditary, Transthyretin-Related
---
https://www.has-sante.fr/jcms/p_3455973/fr/strensiq-asfotase-alfa-hypophosphatasie
2023
false
false
false
France
hypophosphatasia
treatment outcome
insurance, health, reimbursement
enzyme replacement therapy
asfotase alfa
hypophosphatasia
evaluation of the transparency committee
asfotase alfa
---
https://www.has-sante.fr/jcms/p_3456306/fr/novoseven-eptacog-alfa-active-hemorragies-du-post-partum-severes
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
coagulation factor VIIa
recombinant FVIIa
injections, intravenous
evaluation of the transparency committee
eptacog alfa
postpartum hemorrhage
---
https://www.has-sante.fr/jcms/p_3456312/fr/ceprotin-proteine-c-humaine-deficit-congenital-severe-en-proteine-c
2023
false
false
false
France
protein C
treatment outcome
insurance, health, reimbursement
protein c
protein c deficiency
Coumarin necrosis (disorder)
purpura fulminans
venous thrombosis
evaluation of the transparency committee
protein c deficiency
---
https://www.has-sante.fr/jcms/p_3456518/fr/luxturna-voretigene-neparvovec-dystrophie-retinienne-hereditaire
2023
false
false
false
France
Voretigene Neparvovec
treatment outcome
insurance, health, reimbursement
gene therapy
biological products
adult
child
retinal dystrophies
Biallelic RPE65, retinoid isomerohydrolase mutation associated retinal dystrophy (disorder)
RPE65 gene mutation
adolescent
Subretinal Route of Administration
voretigene neparvovec
evaluation of the transparency committee
hereditary retinal dystrophy, nos
retinal dystrophies
---
https://www.has-sante.fr/jcms/p_3456825/fr/pombiliti-cipaglucosidase-alfa-opfolda-miglustat-en-association-forme-tardive-maladie-de-pompe
2023
false
false
false
France
Cipaglucosidase Alfa
cipaglucosidase alfa
Glycogen storage disease type II late onset (disorder)
miglustat
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
miglustat
drug therapy, combination
glycogen storage disease type ii
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/cartographie-optique-du-genome-diagnostic-et-stratification-pronostique-des-hemopathies-malignes.html
2023
Canada
technical report
genome mapping
chromosome mapping
hematologic diseases
Malignant hemopathy
hematologic neoplasms
genome, nos
Hematologic and hematopoietic diseases
Optics
no diagnosis
Hemopathies
diagnosis
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panels-des-cancers-pediatriques-par-sequencage-de-nouvelle-generation-de-lexome-et-du-transcriptome-somatiques.html
2023
Canada
review of literature
family characteristics
sequence determinations
sequence analysis
Pediatricians
generations
transcriptome
pediatrics
exome
pediatrician
---
https://cps.ca/fr/documents/position/la-pharmacotherapie-en-fonction-des-genes-chez-les-enfants
2023
false
false
false
false
false
Canada
pharmacogenetics
Drug-Related side effects and adverse reactions
practice guideline
child
genes
---
https://www.has-sante.fr/jcms/p_3431473/fr/deficits-immunitaires-hereditaires
2023
France
practice guideline
genetic diseases, inborn
Handbook
chronic disease
Diseases
hereditary disease, nos
Chronic disease
chronic disease, nos
Hereditary disease
immunologic deficiency syndromes
hereditary diseases
---
https://ansm.sante.fr/tableau-marr/patisiran
2023
false
false
false
France
French
risk management
patisiran
patisiran
guidelines for drug use
patisiran
infusions, intravenous
Drug-Related side effects and adverse reactions
patient education handout
Adverse reaction caused by drug or medicament administered by infusion (disorder)
Infusion Site Reaction
Infusion Site Reaction
signs and symptoms
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panels-des-predispositions-aux-cancers-pediatriques-par-sequencage-de-nouvelle-generation.html
2023
Canada
review of literature
pediatrician
family characteristics
generations
Pediatricians
pediatrics
disease susceptibility
sequence determinations
sequence analysis
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pathologie-pertinence-et-indications-de-transmission-selective-de-prelevements-chirurgicaux-au-laboratoire-danatomopathologie.html
2023
Canada
practice guideline
Drives
breeding
indication of
suggestive of
pathology, surgical
anatomic pathologist
indicators and reagents
laboratories
---
https://www.has-sante.fr/jcms/p_3460573/fr/kaftrio-ivacaftor-/-tezacaftor-/-elexacafto-en-association-avec-kalydeco-mucoviscidose-enfant-6-ans
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug therapy, combination
drug combinations
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor
ivacaftor
tezacaftor
guidelines for drug use
evaluation of the transparency committee
child
cystic fibrosis
---
https://www.has-sante.fr/jcms/p_3460133/fr/hemgenix-etranacogene-dezaparvovec-hemophilie-b
2023
false
false
false
France
Etranacogene Dezaparvovec
treatment outcome
insurance, health, reimbursement
adult
infusions, intravenous
gene therapy
Gene Therapy Agent
biological products
etranacogene dezaparvovec
evaluation of the transparency committee
hemophilia B
---
https://ansm.sante.fr/actualites/topiramate-epitomax-et-generiques-et-troubles-neurodeveloppementaux-mise-en-place-de-mesures-en-europe-pour-limiter-lutilisation-pendant-la-grossesse
2023
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Topiramate
pregnancy
europe
Neurodevelopmental Disorders
risk
risk management
drug evaluation
Topiramate
france
anticonvulsants
anticonvulsants
anticonvulsants
Topiramate
topiramate
Female of Childbearing Potential
---
https://dumas.ccsd.cnrs.fr/dumas-04142148
2023
France
dissertations, academic
hereditary diseases
cardiomyopathies
hereditary disease, nos
metabolic disease, nos
dilated cardiomyopathy secondary to metabolic disorder
Metabolic Disorder
metabolic diseases
Genetic Disorder
Cardiomyopathy
metabolism, inborn errors
---
https://dumas.ccsd.cnrs.fr/dumas-04149147
2023
France
dissertations, academic
case management
disease
has patient
charge association
CHARGE Syndrome
Patient Load
Polycystic Ovary Syndrome
polycystic ovary syndrome
patient escort service
CHARGE syndrome
polycystic ovaries
Polycystic Ovary Syndrome
---
https://www.inserm.fr/dossier/hemochromatose-genetique/
2023
France
scientific and technical information
gene, nos
hemochromatosis
genetics
Hereditary Hemochromatosis
hemochromatosis, nos
Population Genetics
Cancer Genetics
Gene Therapy
---
https://ansm.sante.fr/informations-de-securite/lamotrigine-lamictal-et-generiques-rappel-du-bon-usage-afin-de-limiter-le-risque-deruption-cutanee-grave-en-particulier-au-debut-du-traitement
2023
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Lamotrigine
Lamotrigine
risk management
lamotrigine
anticonvulsants
anticonvulsants
stevens-johnson syndrome
drug eruptions
Drug-Related side effects and adverse reactions
epidermal necrolysis, toxic
drug hypersensitivity syndrome
adult
child
drug interactions
---
https://anpgm.fr/media/documents/ANPGM_139_v3_Cancer_gastrique_diffus.pdf
2023
France
guideline
genetic predisposition
stomach, nos
genetic predisposition to disease
stomach neoplasms
Genetic Predisposition to Malignant Neoplasm
Genetic Predisposition to Cancer
genetics
neoplasm, malignant
Stomach
diffusion
Gastric Diffuse Adenocarcinoma
cancer of stomach
---
https://ansm.sante.fr/informations-de-securite/prise-en-charge-par-colchicine-de-la-goutte-une-nouvelle-posologie-plus-faible-et-un-message-dalerte-sur-les-boites-pour-reduire-le-risque-de-surdosage
2023
false
false
false
France
French
risk management
colchicine
colchicine
gout
guidelines for drug use
gout suppressants
gout suppressants
colchicine
---
https://ansm.sante.fr/tableau-marr/imiglucerase
2023
false
false
false
France
French
guidelines for drug use
risk management
imiglucerase
imiglucerase
infusions, intravenous
enzyme replacement therapy
home nursing
gaucher disease
home infusion therapy
home infusion therapy
---
https://ansm.sante.fr/informations-de-securite/voxzogo-vosoritide-modification-de-la-seringue-et-de-laiguille-conduisant-a-une-administration-exprimee-en-unites-u-au-lieu-de-ml
2023
false
false
false
France
French
vosoritide
guidelines for drug use
Syringe markings confusion
risk
---
https://www.has-sante.fr/jcms/p_3467298/fr/nexviadyme-avalglucosidase-alfa-maladie-de-pompe
2023
false
false
false
France
enzyme replacement therapy
treatment outcome
insurance, health, reimbursement
avalglucosidase alfa
adult
adolescent
child
guidelines for drug use
infusions, intravenous
evaluation of the transparency committee
glycogen storage disease type ii
Avalglucosidase Alfa
---
https://www.cochrane.org/fr/CD015236/CF_prebiotiques-pour-les-personnes-atteintes-de-mucoviscidose
2023
United Kingdom
review of literature
french abstract
prebiotics
People
Cystic Fibrosis
cystic fibrosis
disease
persons
cystic fibrosis
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panel-pour-la-recherche-de-mutations-myeloides-par-sequencage-de-nouvelle-generation.html
2023
Canada
technical report
generations
Search
Next Generation Sequencing
Novel Mutation
mutation
Research
family characteristics
sequence analysis
research
Myeloid Mutation Panel
sequence determinations
---
https://www.has-sante.fr/jcms/p_3470456/fr/orkambi-lumacaftor/ivacaftor-mucoviscidose-enfant
2023
false
false
false
France
lumacaftor, ivacaftor drug combination
treatment outcome
insurance, health, reimbursement
ivacaftor
lumacaftor
drug combinations
administration, oral
ivacaftor and lumacaftor
Chloride Channel Agonists
cystic fibrosis
CFTR delta F508
guidelines for drug use
evaluation of the transparency committee
infant
cystic fibrosis
---
https://www.has-sante.fr/jcms/p_3470276/fr/pombiliti-cipaglucosidase-alfa-/-opfolda-miglustat-forme-tardive-de-la-maladie-de-pompe
2023
false
false
false
France
Glycogen storage disease type II late onset (disorder)
treatment outcome
insurance, health, reimbursement
drug therapy, combination
enzyme replacement therapy
adult
cipaglucosidase alfa
infusions, intravenous
administration, oral
miglustat
evaluation of the transparency committee
miglustat
glycogen storage disease type ii
Cipaglucosidase Alfa
---
https://www.has-sante.fr/jcms/p_3474022/fr/skyclarys-omaveloxolone-traitement-de-l-ataxie-de-friedreich-af
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
Omaveloxolone
adult
adolescent
guidelines for drug use
administration, oral
capsules
omaveloxolone
evaluation of the transparency committee
friedreich ataxia
---
https://dumas.ccsd.cnrs.fr/dumas-04213427
2023
France
dissertations, academic
Cannabidiol
pain, nos
CHARGE Syndrome
cannabidiol
charge association
Uncharged
Painful
cannabidiol
Chronic Graft Versus Host Disease
Placement
patient care management
Fula Language
CHARGE syndrome
---
https://www.has-sante.fr/jcms/p_3471037/fr/actualisation-2023-utilite-clinique-des-signatures-genomiques-dans-le-cancer-du-sein-rh-/her2-de-stade-precoce
2023
France
health technology assessment
neoplasm staging
Clinical Batch
Medical Examination
early
genome
breast cancer
Clinical Lot
technology assessment
genomics
Early Stage Breast Carcinoma
Genome
Clinical Data
hospitals, proprietary
health
Ambulatory Care Facility
Technology Assessment
neoplasm, malignant
genome, nos
technology assessment, biomedical
breast neoplasms
Signature
Useful
---
https://www.has-sante.fr/jcms/p_3478088/fr/galafold-chlorhydrate-de-migalastat-deficit-en-a-galactosidase-a
2023
false
false
false
France
fabry disease
adolescent
evaluation of the transparency committee
migalastat hydrochloride
migalastat
Migalastat Hydrochloride
galactosidases
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/principes-et-criteres-encadrant-le-recours-au-sequencage-pangenomique-en-trio-parents-enfant-en-genetique-constitutionnelle.html
2023
Canada
technical report
Child Relation
Nucleic Acid Sequencing
Population Genetics
Triple Functional Domain Protein
Gene Therapy
principle-based ethics
parents
Criterion
Cancer Genetics
sequence determinations
policy
Biopolymer Sequencing
Constitutional
gene, nos
TRIO Gene
child
genetics
Child Individual
child, nos
sequence analysis
parent, nos
---
https://www.has-sante.fr/jcms/p_3482344/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine
2023
false
false
false
France
RNAi Therapeutics
treatment outcome
insurance, health, reimbursement
vutrisiran
injections, subcutaneous
amyloid neuropathies, familial
adult
polyneuropathies
evaluation of the transparency committee
amyloidosis, hereditary, Transthyretin-Related
Vutrisiran
---
https://ansm.sante.fr/tableau-marr/avalglucosidase-alfa
2023
false
false
false
France
French
guidelines for drug use
risk management
Infusion-Related Reaction
medication errors
Avalglucosidase Alfa
infusions, intravenous
home infusion therapy
continuity of patient care
enzyme replacement therapy
GAA protein, human
avalglucosidase alfa
monitoring, immunologic
glycogen storage disease type ii
---
https://ansm.sante.fr/informations-de-securite/medicaments-contenant-du-topiramate-epitomax-et-generiques-modification-des-conditions-de-prescription-et-de-delivrance
https://ansm.sante.fr/actualites/topiramate-et-risques-chez-les-enfants-exposes-pendant-la-grossesse-modification-des-conditions-de-prescription-et-de-delivrance-aux-femmes-concernees-5
2023
false
false
false
France
French
abnormalities, drug-induced
Topiramate
Topiramate
teratogens
pregnancy
drug information
topiramate
risk
risk management
In Utero Drug Exposure
Neurodevelopmental Disorders
child
---
https://ansm.sante.fr/tableau-marr/volanesorsen
2023
false
false
false
France
French
guidelines for drug use
patients guideline
volanesorsen
thrombocytopenia
hemorrhage
familial hyperchylomicronemia syndrome
hyperlipoproteinemia type i
Drug-Related side effects and adverse reactions
---
https://www.inspq.qc.ca/publications/2887
2023
Canada
technical report
recessive hereditary disorder, nos
unilateral
Diseases
saints
judgment
persons
hereditary diseases
corpus callosum agenesis neuronopathy
ribs
Hereditary disease
genetic diseases, inborn
---
https://www.ceredih.fr/uploads/CEREDIH_RECO_ANTIBIO_2022_12_16.pdf
2023
France
scientific and technical information
amoxicillin-potassium clavulanate combination
Cefpodoxime
cefpodoxime
has patient
immunologic deficiency syndromes
France
bactrim
cefpodoxime
clamoxyl
France
France
patients
disease
clavulanic acid
france
augmentin
research report
french
albumin/globulin ratio
Cefpodoxime Proxetil
tension
France
amoxycillin with clavulanate potassium
Primary Immunodeficiency Diseases
amoxicillin
primary immune deficiency disorder, nos
---
https://www.anses.fr/fr/renforcer-surveillance-ogm-environnement
2023
France
popular works
Reinforcement, Psychology
Environment
reinforcement, nos
environmental monitoring
organisms, genetically modified
---
https://www.anses.fr/fr/system/files/BIOT2022SA0226.pdf
2023
France
technical report
spain
annual reports as topic
Genetics
albumin/globulin ratio
genets
genetics
Environment
comment
Annual Report
gene, nos
genetta, nos
environmental monitoring
inlets
Genetics
genista
aspartate aminotransferases
portugal
bays
Genetics
surveillance culture, nos
---
https://www.health.belgium.be/fr/avis-9414-besoins-nutritionnels-des-patients-souffrant-de-mucoviscidose
2023
Belgium
technical report
nutritional requirement
nutritional requirements
needs
cystic fibrosis
cystic fibrosis
patient need for
Cystic fibrosis
judgment
patients
---
https://www.cancer.fr/catalogue-des-publications/patients-atteints-d-un-cancer-bronchique-non-a-petites-cellules-indications-des-tests-moleculaires-en-vue-de-la-prescription-de-traitements-de-pr
https://www.cancer.fr/catalogue-des-publications/patients-atteints-d-un-cancer-bronchique-non-a-petites-cellules-indications-des-tests-moleculaires-en-vue-de-la-prescription-de-traitements-de-pr2
2023
false
false
false
France
molecular diagnostic techniques
practice guideline
patients
carcinoma, non-small-cell lung
---
https://www.has-sante.fr/jcms/p_3408892/fr/crysvita-burosumab-hypophosphatemie-liee-au-fgf23-chez-les-patients-ages-d-1-an-et-plus
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
burosumab
burosumab
injections, subcutaneous
infant
child
adolescent
adult
Phosphaturic Mesenchymal Tumor
oncogenic osteomalacia
hypophosphatemia
Fibroblast Growth Factor-23
FGF23-related hypophosphataemia
evaluation of the transparency committee
---
https://apps.who.int/iris/handle/10665/366031
2023
Switzerland
journal article
capacity building
genome, nos
epidemics
paraguay
untrained personnel
volunteers
Public health
public health
reinforcement, nos
health personnel
health education
brazil
medical laboratory personnel
laboratory personnel
genomics
---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-marion-fiorentino-robinson-gravier-dumonceau-mazelier
2023
France
audiovisual aids
Systematics
Africa
Systematic Review
Taxonomy
sex ratio
classification
Africa
men
Africa
Africa
Systematics
review literature as topic
Literature
africa
women
coitus
Africa
Africa
Systematics
sexual intercourse, nos
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panels-de-la-deficience-intellectuelle-et-du-retard-global-du-developpement-par-sequencage-de-nouvelle-generation.html
2023
Canada
review of literature
intellectual disability
developmental disabilities
child development disorders, specific
family characteristics
sequence determinations
Intellectual deficiency
failure to thrive
impairment
Intellectual deficiency
generations
Intellectual deficiency
Intellectual deficiency
Intellectual deficiency
sequence analysis
---
https://www.has-sante.fr/jcms/p_3418145/fr/livmarli-maralixibat-syndrome-d-alagille
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
maralixibat chloride
infant
child
Cholestatic pruritus (disorder)
administration, oral
orphan drug production
evaluation of the transparency committee
maralixibat
alagille syndrome
---
https://www.sf2h.net/publications/recommandations-relatives-aux-indications-du-diagnostic-de-la-covid-19.html
2023
false
false
false
France
molecular biology
guideline
COVID-19
hospitals
---
https://www.cochrane.org/fr/CD013733/CF_les-technologies-numeriques-aident-elles-les-personnes-atteintes-de-mucoviscidose-respecter-leurs
2023
United Kingdom
review of literature
french abstract
inspiration
cystic fibrosis
administration, inhalation
cystic fibrosis
Cystic fibrosis
patient compliance
Technology
persons
disease
technology
Respect
inhalers
---
https://www.has-sante.fr/jcms/p_3403913/fr/atteinte-pulmonaire-associee-a-un-deficit-en-alpha1-antitrypsine
2023
false
false
false
France
alpha 1-antitrypsin deficiency
lung diseases
alpha 1-antitrypsin deficiency
alpha 1-antitrypsin deficiency
practice guideline
---
https://www.sfdiabete.org/sites/www.sfdiabete.org/files/files/ressources/1-s2.0-s1957255723000159-main.pdf
2023
false
false
false
France
Glucose intolerance
glucose intolerance
Cystic fibrosis related diabetes
practice guideline
cystic fibrosis
diabetes mellitus
---
https://apps.who.int/iris/handle/10665/366577
2023
false
false
false
Switzerland
journal article
blood group antigen m1a
blood group antigen hg a
blood group antigen pr a
genetta, nos
blood group antigen ok a
blood group antigen r1a
blood group antigen sd a
blood group antigen jk a
blood group antigen kp a
Genetics
blood group antigen fr a
blood group antigen at a
blood group antigen yh a
blood group antigen tg a
blood group antigen fy a
blood group antigen jc a
blood group antigen en ats
Viruses
blood group antigen le d
blood group antigen u1a
blood group antigen a.m.
blood group antigen ch a
blood group antigen sf a
blood group antigen cr3
blood group antigen li a
blood group antigen lan
blood group antigen in a
blood group antigen co a
blood group antigen tr a
antigen, nos
blood group antigen lu a
blood group antigen go a
blood group antigen th a
blood group antigen bp a
blood group antigen ht a
blood group antigen en afs
blood group antigen kn a
antigens
blood group antigen pt a
blood group antigen dh a
blood group antigen chr a
blood group antigen or a
blood group antigen jr a
genets
cytisus
Antigens
blood group antigen wk a
due to
blood group antigen pr a
blood group antigen ny a
blood group antigen s1a
blood group antigen dr a
blood group antigen cl a
blood group antigen le x
blood group antigen os a
blood group antigen bg a
blood group antigen le a
Genetics
blood group antigen c
blood group antigen en afr
blood group antigen le c
blood group antigen au a
viverridae
blood group antigen a1 le d
blood group antigen en akt
blood group antigen le b
blood group antigen sk a
blood group antigen rg a
blood group antigen yt a
blood group antigen a1b
blood group antigen vr
blood group antigen le bh
blood group antigen rd a
blood group antigen a1 le b
blood group antigen a.m.
blood group antigen le s
Virus
viruses
blood group antigen sc2
blood group antigen ls a
blood group antigen a2b
blood group antigen to a
Preparation
blood group antigen n a
blood group antigen an a
blood group antigen lw b
blood group antigen ol a
blood group antigen vg a
gene, nos
blood group antigen sw a
blood group antigen jo a
blood group antigen cs a
blood group antigen ri a
blood group antigen wd a
blood group antigen do a
blood group antigen m a
blood group antigen er a
blood group antigen es a
blood group antigen rb a
blood group antigen a3b
blood group antigen wr a
blood group antigen zt a
blood group antigen di a
blood group antigen mi a
blood group antigen lw a
blood group antigen nijhuis
blood group antigen bx a
Genetics
blood group antigen st a
blood group antigen be a
blood group antigen re a
blood group antigen mt a
blood group antigen mo a
blood group antigen xg a
blood group antigen yk a
blood group antigen c
virus, nos
pandemics
blood group antigen rh a
blood group antigen a3
blood group antigen gy a
blood group antigen 'n'
blood group antigen jn a
blood group antigen js a
blood group antigen mcc a
blood group antigen a2
blood group antigen rh42
blood group antigen a x
blood group antigen le ns
blood group antigen m'
blood group antigen je a
blood group antigen tj a
blood group antigen le bl
genetics
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-neonatal-sanguin-par-spectrometrie-de-masse-en-tandem-derreurs-innees-du-metabolisme-asa-ga1-lchadd-tfpd-vlcadd.html
2023
Canada
technical report
Mass spectrometry
neonatal screening, nos
tandem mass spectrometry
metabolism, inborn errors
blood volume, nos
mass screening
aspirin
metabolic disease, nos
Metabolism
neonatal screening
---
https://www.enfant-encyclopedie.com/hyperactivite-et-inattention-tdah/selon-experts/les-contributions-genetiques-au-tdah
2023
Canada
scientific and technical information
Genetics
cytisus
genetics
attention deficit disorder with hyperactivity
Genetics
viverridae
gene, nos
genets
genetta, nos
Genetics
---
https://ansm.sante.fr/tableau-marr/alglucosidase-alpha
2023
false
false
false
France
French
guidelines for drug use
risk management
alpha-Glucosidases
alpha-Glucosidases
alpha-Glucosidases
---
https://www.has-sante.fr/jcms/p_3427763/fr/bylvay-odevixibat-prurit-cholestatique-associe-au-syndrome-d-alagille
2023
false
false
false
France
cholestatic pruritus in Alagille syndrome
infant
child
guidelines for drug use
treatment outcome
insurance, health, reimbursement
administration, oral
odevixibat
evaluation of the transparency committee
pruritus
alagille syndrome
odevixibat
---
https://interstices.info/le-sars-cov-2-une-experience-inedite-de-surveillance-genomique-mondiale/
2023
France
scientific and technical information
SARS-CoV-2
genome, nos
genomics
organization and administration
---
https://www.cancer.fr/catalogue-des-publications/activite-des-plateformes-de-genetique-moleculaire-des-cancers-en-2019-2020-rapport-d-activite
https://www.cancer.fr/catalogue-des-publications/activite-des-plateformes-de-genetique-moleculaire-des-cancers-en-2019-2020-synthese-du-rapport-d-activite
2023
false
false
false
France
technical report
albumin/globulin ratio
research report
Molecular genetics
Molecular genetics
gene, nos
genetics, molecular
molecular biology
---
https://ansm.sante.fr/tableau-marr/elosulfase-alfa
2023
false
false
false
France
French
guidelines for drug use
risk management
elosulfase alfa
elosulfase alfa
infusions, intravenous
infusion rate
drug dosage calculations
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-dajouter-les-variantes-hbs-e-hbe-e-et-hbe-b-thal-aux-cibles-primaires-du-test-de-depistage-neonatal-des-hemoglobinopathies.html
2023
Canada
public health guidelines
hemoglobinopathy, nos
hemoglobinopathies
principal
neonatal screening, nos
Hemoglobinopathy
neonatal screening
dermatomyositis
---
https://dumas.ccsd.cnrs.fr/dumas-04061185
2023
France
Diseases
disease, nos
cystic fibrosis
cystic fibrosis
disease
Cystic fibrosis
Rare disease
rare diseases
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/principes-et-criteres-de-selection-des-genes-pour-le-diagnostic-moleculaire-des-maladies-en-genetique-constitutionnelle-par-sequencage-de-nouvelle-generation-sng.html
2023
Canada
technical report
Molecular genetics
policy
disease
family characteristics
generations
genetics, molecular
genetic selection
Genetic disease
principle-based ethics
nasogastric tube
pathology, molecular
Diseases
no diagnosis
selection, genetic
selection criteria
hereditary disease, nos
sequence analysis
genetic diseases, inborn
diagnosis
Molecular genetics
genes
patient selection
sequence determinations
---
https://ansm.sante.fr/tableau-marr/atidarsagene-autotemcel
2023
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
Atidarsagene Autotemcel
risk management
infusions, intravenous
gene therapy
atidarsagene autotemcel
biological products
---
https://ansm.sante.fr/tableau-marr/agalsidase-beta
2023
false
false
false
France
French
risk management
agalsidase beta
guidelines for drug use
patients guideline
infusions, intravenous
enzyme replacement therapy
fabry disease
continuity of patient care
home health nursing
---
https://ansm.sante.fr/tableau-marr/asfotase-alfa
2023
false
false
false
France
French
risk management
guidelines for drug use
asfotase alfa
asfotase alfa
self administration
patients guideline
child
injections, subcutaneous
enzyme replacement therapy
asfotase alfa
hypophosphatasia
---
https://ansm.sante.fr/tableau-acces-derogatoire/nexviadyme-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2023
false
false
false
France
French
summary of product characteristics
package leaflet
infusions, intravenous
Avalglucosidase Alfa
glycogen storage disease type ii
guidelines for drug use
---
https://www.afm-telethon.fr/fr/fiches-maladies/dystrophies-musculaires-congenitales
2022
France
popular works
muscular dystrophies
Muscular dystrophy
congenital dystrophy, nos
congenital muscular dysdrophy
muscular dystrophy, nos
---
https://www.afm-telethon.fr/fr/fiches-maladies/syndromes-myastheniques-congenitaux
2022
France
popular works
myasthenic syndromes, congenital
Myasthenia gravis
---